Russell Investments Group Ltd. lowered its position in Molina Healthcare, Inc. (NYSE:MOH – Free Report) by 51.5% during the second quarter, HoldingsChannel reports. The institutional investor owned 70,973 shares of the company’s stock after selling 75,255 shares during the period. Russell Investments Group Ltd.’s holdings in Molina Healthcare were worth $21,317,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its position in Molina Healthcare by 2,950.0% during the first quarter. EverSource Wealth Advisors LLC now owns 122 shares of the company’s stock worth $33,000 after purchasing an additional 118 shares during the period. Coppell Advisory Solutions Corp. bought a new stake in Molina Healthcare during the fourth quarter worth approximately $34,000. Brown Brothers Harriman & Co. bought a new stake in Molina Healthcare during the first quarter worth approximately $40,000. Parkside Financial Bank & Trust boosted its position in Molina Healthcare by 85.9% during the first quarter. Parkside Financial Bank & Trust now owns 132 shares of the company’s stock worth $44,000 after purchasing an additional 61 shares during the period. Finally, Cullen Frost Bankers Inc. bought a new stake in shares of Molina Healthcare in the second quarter valued at approximately $51,000. Institutional investors and hedge funds own 98.11% of the company’s stock.
Insiders Place Their Bets
In other news, Director Steven J. Orlando sold 1,134 shares of the firm’s stock in a transaction on Monday, October 30th. The stock was sold at an average price of $325.96, for a total value of $369,638.64. Following the completion of the sale, the director now directly owns 19,299 shares in the company, valued at $6,290,702.04. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Steven J. Orlando sold 1,134 shares of Molina Healthcare stock in a transaction dated Monday, October 30th. The stock was sold at an average price of $325.96, for a total transaction of $369,638.64. Following the transaction, the director now owns 19,299 shares in the company, valued at approximately $6,290,702.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Maurice Hebert sold 692 shares of Molina Healthcare stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $328.15, for a total value of $227,079.80. Following the transaction, the chief accounting officer now owns 8,528 shares in the company, valued at approximately $2,798,463.20. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.
Molina Healthcare Stock Performance
Molina Healthcare (NYSE:MOH – Get Free Report) last released its quarterly earnings data on Wednesday, October 25th. The company reported $5.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.87 by $0.18. Molina Healthcare had a return on equity of 34.85% and a net margin of 2.80%. The firm had revenue of $8.55 billion during the quarter, compared to analyst estimates of $8.24 billion. During the same period in the prior year, the company posted $4.36 earnings per share. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, analysts anticipate that Molina Healthcare, Inc. will post 20.83 EPS for the current fiscal year.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on MOH shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $359.00 price objective on shares of Molina Healthcare in a research report on Thursday, September 14th. Stephens reissued an “equal weight” rating and issued a $350.00 price objective on shares of Molina Healthcare in a research report on Tuesday, October 3rd. StockNews.com upgraded Molina Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Thursday, October 12th. Bank of America upped their target price on Molina Healthcare from $340.00 to $350.00 in a research note on Thursday, July 27th. Finally, JPMorgan Chase & Co. upped their target price on Molina Healthcare from $367.00 to $392.00 and gave the company an “overweight” rating in a research note on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $348.45.
Molina Healthcare Profile
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
- Five stocks we like better than Molina Healthcare
- Consumer Discretionary Stocks Explained
- Safeguard your portfolio with these three bargain stocks
- How to Invest in Grocery Stores
- Membership clubs gain leverage for the consumer rebound
- Canada Bond Market Holiday: How to Invest and Trade
- Advanced Auto Parts may be worth more in pieces than the whole
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.